AAD 2022 HAIRCARE ROUTINE TO TREAT THE TELOGEN EFFLUVIUM ASSOCIATED TO POST COVID-19 INFECTION
AAD 2022 HAIRCARE ROUTINE TO TREAT THE TELOGEN EFFLUVIUM ASSOCIATED TO POST COVID-19 INFECTION
Publication date: March 2024
Updated date: July 2026
Reading time:10 min (reading time)
INTRODUCTION
Telogen effluvium (TE) is characterized by diffuse hair shedding 2-3 months after a stress factor such as fever, hypoxia, inflammation (Interleukin-6) and medications
Need for mechanical ventilation may play a role in the development and severity of TE caused by COVID-19